Dietary n-3 LCPUFA from fish oil but not α-linolenic acid-derived LCPUFA confers atheroprotection in mice

Journal of Lipid Research

Volumn 51, Issue 7, 2010, Pages 1897-1905

  Degirolamo, Chiara ^a   Kelley, Kathryn L ^a   Wilson, Martha D ^a   Rudel, Lawrence L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cholesteryl ester; Lipoprotein metabolism; Liver; Long chain polyunsaturated fatty acid

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL OLEATE; FISH OIL; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LINSEED OIL; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; CHOLESTEROL; EDIBLE OIL; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FEMALE; LIPID ANALYSIS; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ALPHA-LINOLENIC ACID; ANIMALS; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHOLESTEROL; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL;

EID: 77953526791     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M005058     Document Type: Article

References (45)

1. Kris-Etherton, P. M., K. D. Hecker, and A. E. Binkoski. 2004. Polyunsaturated fatty acids and cardiovascular health. Nutr. Rev. 62: 414-426.
2. Demaison, L., and D. Moreau. 2002. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell. Mol. Life Sci. 59: 463-477.
3. Lichtenstein, A. H., L. J. Appel, M. Brands, M. Carnethon, S. Daniels, H. A. Franch, B. Franklin, P. Kris-Etherton, W. S. Harris, B. Howard, et al. 2006. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation. 114: 82-96.
4. Jump, D. B. 2002. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277: 8755-8758.
5. Williams, C. M., and G. Burdge. 2006. Long-chain n-3 PUFA: plant v. marine sources. Proc. Nutr. Soc. 65: 42-50.
6. Burdge, G. C., and P. C. Calder. 2005. α-linolenic acid metabolism in adult humans: the effects of gender and age on conversion to longer chain polyunsaturated fatty acids. Eur. J. Lipid Sci. Technol. 107: 426-439.
7. Sanders, T. A., and K. M. Younger. 1981. The effect of dietary supplements of omega 3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglycerides. Br. J. Nutr. 45: 613-616.
8. Baylin, A., E. K. Kabagambe, A. Ascherio, D. Spiegelman, and H. Campos. 2003. Adipose tissue alpha-linolenic acid and non-fatal acute myocardial infarction in Costa Rica. Circulation. 107: 1586-1591.
9. Campos, H., A. Baylin, and W. C. Willett. 2008. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation. 118: 339-345.
10. Hu, F. B., M. J. Stampfer, J. E. Manson, E. B. Rimm, A. Wolk, G. A. Colditz, C. H. Hennekens, and W. C. Willett. 1999. Am. J. Clin. Nutr. 69: 890-897.
11. Prasad, K. 1997. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 132: 69-76. (Pubitemid 27306741)
12. Dupasquier, C. M., E. Dibrov, A. L. Kneesh, P. K. M. Cheung, K. G. Y. Lee, H. K. Alexander, B. K. Yeganeh, M. H. Moghadasian, and G. N. Pierce. 2007. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am. J. Physiol. Heart Circ. Physiol. 293: H2394-H2402.
13. Pellizzon, M. A., J. T. Billheimer, L. T. Bloedon, P. Szapary, and D. J. Rader. 2007. Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. J. Am. Coll. Nutr. 26: 66-75.
14. Prasad, K. 2009. Flaxseed and cardiovascular health. J. Cardiovasc. Pharmacol. 54: 369-377.
15. -/- mice. Arterioscler. Thromb. Vasc. Biol. 27: 1396-1402.
16. -/- mice. J. Lipid Res. 48: 1122-1131.
17. Willner, E. L., B. Tow, K. K. Buhman, M. Wilson, D. A. Sanan, L. L. Rudel, and R. V. Farese, Jr. 2003. Deficiency of acyl-CoA: cholesterol acyltransferase 2 prevents atherosclerosis in apoliprotein E-deficient mice. Proc. Natl. Acad. Sci. USA. 100: 1262-1267.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
19. Temel, R. E., R. G. Lee, K. L. Kelley, M. A. Davis, R. Shah, J. K. Sawyer, M. D. Wilson, and L. L. Rudel. 2005. Intestinal cholesterol absorption is substancially reduced in mice deficient in both ABCA1 and ACAT2. J. Lipid Res. 46: 2423-2431.
20. Rudel, L. L., J. S. Parks, and J. K. Sawyer. 1995. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 2101-2110.
21. Rudel, L. L., K. L. Kelley, J. K. Sawyer, R. Shah, and M. D. Wilson. 1998. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100-overexpressing transgenic mice. Arterioscler. Thromb. Vasc. Biol. 18: 1818-1827.
22. Degirolamo, C., G. S. Shelness, and L. L. Rudel. 2009. LDL cholesteryl oleate as predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J. Lipid Res. 50( Suppl ): S434-S439.
23. Lee, R. G., M. C. Willingham, M. A. Davis, K. A. Skinner, and L. L. Rudel. 2000. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J. Lipid Res. 41: 1991-2001.
24. Carr, T. P., J. S. Parks, and L. L. Rudel. 1992. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler. Thromb. 12: 1274-1283.
25. Rudel, L. L., J. Haines, J. K. Sawyer, R. Shah, M. D. Wilson, and T. P. Carr. 1997. Hepatic origin of cholesteryl oleate in coronoary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J. Clin. Invest. 100: 74-83.
26. Lee, R. G., K. L. Kelley, J. K. Sawyer, R. V. Farese, Jr., J. S. Parks, and L. L. Rudel. 2004. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Circ. Res. 95: 998-1004.
27. Parini, P., M. Davis, A. T. Lada, S. K. Erickson, T. L. Wright, U. Gustafsson, S. Sahlin, C. Einarsson, B. Angelin, H. Tomoda, et al. 2004. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation. 110: 2017-2023.
28. Coleman, R. A., T. M. Lewin, C. G. Van Horn, and M. R. Gonzalez-Baró. 2002. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 132: 2123-2126.
29. Seo, T., P. M. Oelkers, M. R. Giattina, T. S. Worgall, S. L. Sturley, and R. J. Deckelbaum. 2001. Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells. Biochemistry. 40: 4756-4762.
30. Burdge, G. C., A. E. Jones, and S. A. Wootton. 2002. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br. J. Nutr. 88: 355-363.
31. Kelley, D. S., G. J. Nelson, J. E. Love, L. B. Branch, P. C. Taylor, P. C. Schmidt, B. E. Mackey, and J. M. Iacono. 1993. Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans. Lipids. 28: 533-537.
32. Harper, C. R., M. J. Edwards, A. P. Defilipis, and T. A. Jacobson. 2006. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J. Nutr. 136: 83-87.
33. Wang, C., W. S. Harris, M. Chung, A. H. Lichtenstein, E. M. Balk, B. Kupelnick, H. S. Jordan, and J. Lau. 2006. n-3 fatty acids from fish or fish oil-supplements but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 84: 5-17.
34. Brenna, J. T. 2002. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care. 5: 127-132.
35. Parks, J. S., and L. L. Rudel. 1990. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis. 84: 83-94. (Pubitemid 20360851)
36. Brown, J. M., G. S. Shelness, and L. L. Rudel. 2007. Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr. Atheroscler. Rep. 9: 494-500.
37. Vasandani, C., A. I. Kafrouni, A. Caronna, Y. Bashmakov, M. Gotthardt, J. D. Horton, and D. K. Spady. 2002. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J. Lipid Res. 43: 772-784. (Pubitemid 34477905)
38. Parks, J. S., M. D. Wilson, F. L. Johnson, and L. L. Rudel. 1989. Fish oil decreases hepatic cholesteryl ester secretion but not apoB secretion in African green monkeys. J. Lipid Res. 30: 1535-1544.
39. Rudel, L. L., J. S. Parks, F. L. Johnson, and J. Babiak. 1986. Low density lipoproteins in atherosclerosis. J. Lipid Res. 27: 465-474.
40. Bordoni, A., M. Di Nunzio, F. Danesi, and P. L. Biagi. 2006. Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors. Genes Nutr. 1: 95-106.
41. Renier, G., E. Skamene, J. DeSanctis, and D. Radzioch. 1993. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler. Thromb. 13: 1515-1524. (Pubitemid 23303406)
42. Blok, W. L., M. B. Katan, and J. W. M. Van der Meer. 1996. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 126: 1515-1533. (Pubitemid 26182386)
43. Harris, W. S. 1997. N-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65: 1645S-1654S.
44. Alpha Omega Trial: A Randomized, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients with a History of Myocardial Infarction. http:\\www.clinicaltrials.gov\ct2\show\NCT00127452?term=alpha+omega+trial& rank=1.
45. Harris, W.S. 2005. Alpha-linolenic acid: a gift from the land? Circulation. 111: 2872-2874.